Skip to content

Pharmaceutical Crystallization Summit

Breaking Drug Development Bottlenecks via Enabling Technologies

October 14-15, 2021

  • Home
  • Program
    • Program for Live Attendance
    • Program for Virtual Attendance
  • Abstracts
    • Session 1: Smarter Solid Form & Pre-formulation Studies
    • Session 2: Particle Engineering & DS-DP Co-Processing
    • Session 3: Physical Property Based Crystallization Process Development
  • Keynote Speakers & Moderators
  • Venue
    • Chauncey Hotel & Conference Center
    • COVID-19 Safety Protocols
    • Destination Guide
  • Partners
    • Center for Pharma Crystallization
    • J-STAR Research, Inc.
    • Porton Pharma Solutions Ltd.
    • XtalPi
    • BlazeMetrics
    • Technobis Crystallization Systems
  • COVID-19 Prevention
    • Chauncey’s Health & Safety Plan
    • PCS COVID-19 Prevention

Session 3: Physical Property Based Crystallization Process Development

Moderator: Dr. Yuriy Abramov, XtalPi

The Importance of Understanding and Characterising the Physical & Chemical Properties of APIs in the Digital Design of Drug Products

Prof. Kevin Roberts, University of Leeds

Read More

Continuous Crystallization and Purification: The Role of Impurity Incorporation Mechanism in Non-Equilibrium Processes

Prof. Allan Myerson, MIT

Read More

Co-Crystals Platform to Improve Physical Properties of Early Intermediates during API Manufacturing Process

Dr. Samir Kulkarni, Pfizer

Read More

Correlation of Solubility with the Metastable Limit

Prof. Ken Morris, Long Island University

Read More

Abstracts

  • Abstracts (15)
    • Session 1: Smarter Solid Form & Pre-formulation Studies (4)
    • Session 2: Particle Engineering & DS-DP Co-Processing (4)
    • Session 3: Physical Property Based Crystallization Process Development (4)
    • Session 4: Topical Panel Discussions (3)

© 2021 Pharmaceutical Crystallization Summit. All Rights Reserved.

Scroll To Top